Christie Akpoigho Enuku
,
Oritsegbemi Orru
For correspondence:- Christie Enuku Email: akpoigho@yahoo.com Tel: +2348052419497
Published: 31 December 2016
Citation: Enuku CA, Orru O. Awareness of tetanus toxoid vaccination by pregnant women attending antenatal clinic in central hospital, Benin City. J Sci Pract Pharm 2016; 3(1):92-96 doi: 10.47227/jsppharm.v3i1.3
© 2016 The author(s).
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only. .
Purpose: Tetanus could occur during pregnancy or within six weeks after delivery. World Health Organization (WHO) introduced Tetanus Toxoid vaccine as one of the primary vaccines targeting Maternal and Neonatal Tetanus. The purpose of the study is to assess the level of awareness of tetanus toxoid (TT) vaccination during pregnancy among pregnant women attending Antenatal Clinic in Central Hospital, Benin City.
Methods: This was a cross-sectional descriptive survey involving a convenient sample of 300 pregnant women that attended antenatal clinic between 5th May and 9th June 2015. Using a close ended questionnaire, the women were asked about their biography, awareness and knowledge of vaccination schedule and number of vaccine received. Data collected were analysed using descriptive statistics.
Results: Majority 140 (47%) of the respondents were in their second trimester while 95(33%) were in their third trimester. Awareness of the TT vaccination during pregnancy was high (80% of respondents) and most respondents had good knowledge of TT 203(69%). Majority 60% of the respondents had received TT1, 22% had received TT2 and 13% had received TT3.
Conclusion: Majority of the pregnant women were aware and knowledgeable of TT vaccination and majority received at least one dose. Vigorous campaigns should be put in place in order to increase their knowledge as regards the 5 doses recommended by WHO
